Cookies

We use cookies to ensure that we give you the best experience on our website. If you click accept my preferences we'll assume that you are happy to receive all cookies on our website. Visit our Cookie Policy and our Privacy Policy for more information about managing your cookies.


Current preferences

Ovarian cancer special report

A must-read for clinical oncologists, gynaecologists, and GPs or medical professionals with an interest in oncology, the report is free to download to readers of GM and BJFM.

 

 

 

 

 

 

 

 

 Register below today to download your free digital copy.

Contents

 

Introduction: An overview of ovarian cancer

 

Alison Bloomer, GM editor

• What is ovarian cancer?
• Risk factors
• Symptoms
• Prevalence
• Screening
• Diagnosis

Ovarian cancer and primary care

Louise Newson, GP

Historically, ovarian cancer has been referred to as the “silent killer” because it was believed that no symptoms were evident in early disease. Overall the five year survival rate from ovarian cancer is poor at around 30-40%. For women diagnosed with early stage disease, the five year survival rate is over 70%, but only a fifth of cases are diagnosed early.* Primary care plays an important role in early detection of ovarian cancer. This article will look at:

• The important role of primary care
• Red flags
• When to refer?
• Testing
• Management in primary care

New advances in the management of ovarian cancer

Alison Bloomer, GM editor

There have been a number of new advances in the field of ovarian cancer from how new information about how much BRCA1 and BRCA2 gene mutations increase ovarian cancer risk is helping women make practical decisions about prevention to early detection strategies. There have also been a number of new targeted treatment options. This article will look at:

• Stages of ovarian cancer
• Current treatment options
• New advances
• Guidelines

The role of research: an article from Ovarian Cancer Action

Ovarian Cancer Action strives to stop women dying from ovarian cancer by funding world-class scientific research leading to innovative treatment and progressive solutions. This article will look at:

• How the charity is working to beat ovarian cancer sooner
• Screening programmes
• Research projects
• Challenges of chemotherapy
• Why does it keep coming back?

*Ref: http://www.bmj.com/content/339/bmj.b3286